8-KOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Corporate Update (Dec 4, 2007)

Filed December 4, 2007For Securities:COR

Summary

AmerisourceBergen Corporation (now Cencora, Inc.) announced on December 3, 2007, a significant development in its relationship with Medco Health Solutions, Inc. The company has signed a letter of intent to become Medco's prime vendor for PBM mail-order wholesaler services, pending the finalization of a new five-year contract. This agreement is set to replace their current contract, which was slated to expire on March 31, 2008. In addition to this strategic vendor agreement, AmerisourceBergen provided updated financial guidance. The company expects its diluted earnings per share for the first quarter of fiscal year 2008 to be positive, and reaffirmed its full fiscal year 2008 diluted earnings per share projection to be within the range of $2.77 to $2.95. This news is crucial for investors as it indicates a strengthened business relationship and provides clarity on the company's near-term and full-year financial outlook.

Key Highlights

  • 1AmerisourceBergen signed a letter of intent to be Medco's prime vendor for PBM mail-order wholesaler services.
  • 2A new five-year contract with Medco is pending finalization.
  • 3This agreement will succeed the current contract expiring March 31, 2008.
  • 4The company announced positive expectations for diluted earnings per share in Q1 fiscal 2008.
  • 5AmerisourceBergen affirmed its fiscal year 2008 diluted EPS guidance to be between $2.77 and $2.95.

Frequently Asked Questions

The main news is AmerisourceBergen's announcement that it has signed a letter of intent to be Medco's prime vendor for PBM mail-order wholesaler services, pending a new five-year contract. The company also provided updated financial guidance for fiscal year 2008.

The letter of intent signifies AmerisourceBergen's selection as Medco's primary vendor for mail-order wholesaler services, indicating a continued and potentially expanded business relationship. The finalization of a new five-year contract is expected to provide revenue stability and growth opportunities in this segment.

The company expects positive diluted earnings per share for the first quarter of fiscal year 2008 and has reaffirmed its full fiscal year 2008 diluted earnings per share guidance to be in the range of $2.77 to $2.95.

The current five-year contract with Medco was scheduled to end on March 31, 2008.